Ray Dalio's position in Gilead Sciences is currently worth $75.1M. That's 0.29% of their equity portfolio (66th largest holding). The first Gilead Sciences trade was made in Q2 2009. Since then Ray Dalio bought shares 28 more times and sold shares on 22 occasions. The stake costed the investor $52M, netting the investor a gain of 44% so far.